BSE filing, NSE: SIGNPOST. Summary written from the filing by ALFA Finder's alert engine.
Signpost India Ltd: key numbers
- Share price
- ₹237.95
- Market cap
- ₹1,272 Cr
- Revenue (annual)
- ₹575.9 Cr
- Net profit (annual)
- ₹70.11 Cr
- P/E (TTM)
- 17.3×Sector 28.6×
- Promoter holding
- 60.38%+0.00% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Signpost India Ltd
All →Signpost India Board Meeting Date
Signpost India Ltd scheduled its Board of Directors meeting for 2 Nov 2026 to consider Q2/H1 FY26-27 results. No financial figures are disclosed in this advance intimation.
Signpost India Bags ₹36 Cr Order from Chalo Mobility Private Limited
Signpost India secured a 5-year contract from Chalo Mobility for exclusive advertising rights on premium buses in Mumbai, valued at approximately ₹36 Crore.
- Value
- ₹36.00 Cr
- From
- Chalo Mobility Private Limited
- Execution
- 5 years
Signpost India Management Change
Signpost India Limited has announced the appointment of Ms. Meghna Rajadhyaksha as a Non-Executive Independent Director and the re-appointment of Mr. Dipankar Chatterjee as Executive Director.
Signpost India Annual General Meeting
The 19th Annual General Meeting was held on September 23, 2026. Shareholders approved resolutions, including director re-appointments and appointments.
Signpost India Price Movement Clarification
Signpost India clarified that the recent significant increase in its share trading volume is purely market-driven. The company confirmed no undisclosed material information exists.
Signpost India Business Update
Signpost India Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26. The report is part of the company's annual report.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.